{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T13:13:17Z","timestamp":1775481197449,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Top Priority Research Center of Shanghai\u2014Plastic Surgery Research Center, Shanghai","award":["2023ZZ02023"],"award-info":[{"award-number":["2023ZZ02023"]}]},{"name":"Major and Key Cultivation Projects of Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine","award":["JYZP005"],"award-info":[{"award-number":["JYZP005"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["YG2023ZD13"],"award-info":[{"award-number":["YG2023ZD13"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-024-05790-2","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T06:03:00Z","timestamp":1727157780000},"page":"5001-5011","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Advancing randomized controlled trials of vascular anomalies: an analysis of trial waste"],"prefix":"10.1007","volume":"183","author":[{"given":"Hongrui","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanchun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,24]]},"reference":[{"issue":"4","key":"5790_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S1064-7406(23)00479-0","volume":"9","author":"JJ Marler","year":"2001","unstructured":"Marler JJ, Mulliken JB (2001) Vascular anomalies: classification, diagnosis, and natural history. Facial Plast Surg Clin North Am 9(4):495\u2013504","journal-title":"Facial Plast Surg Clin North Am"},{"issue":"4","key":"5790_CR2","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.3390\/ijms23042358","volume":"23","author":"K Kunimoto","year":"2022","unstructured":"Kunimoto K, Yamamoto Y, Jinnin M (2022) ISSVA classification of vascular anomalies and molecular biology. Int J Mol Sci 23(4):2358","journal-title":"Int J Mol Sci"},{"issue":"12","key":"5790_CR3","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.3390\/jcm13123515","volume":"13","author":"D Vrinceanu","year":"2024","unstructured":"Vrinceanu D et al (2024) New insights into cervicofacial vascular anomalies. J Clin Med 13(12):3515","journal-title":"J Clin Med"},{"issue":"1","key":"5790_CR4","doi-asserted-by":"publisher","first-page":"e30758","DOI":"10.1002\/pbc.30758","volume":"71","author":"R Kalbfell","year":"2024","unstructured":"Kalbfell R et al (2024) Infectious complications of vascular anomalies treated with sirolimus: a systematic review. Pediatr Blood Cancer 71(1):e30758","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"5790_CR5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.hoc.2019.01.011","volume":"33","author":"DM Adams","year":"2019","unstructured":"Adams DM, Ricci KW (2019) Vascular anomalies: diagnosis of complicated anomalies and new medical treatment options. Hematol Oncol Clin North Am 33(3):455\u2013470","journal-title":"Hematol Oncol Clin North Am"},{"issue":"11","key":"5790_CR6","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/bjs.11266","volume":"106","author":"SJ Chapman","year":"2019","unstructured":"Chapman SJ et al (2019) Research waste in surgical randomized controlled trials. Br J Surg 106(11):1464\u20131471","journal-title":"Br J Surg"},{"issue":"6","key":"5790_CR7","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1159\/000533675","volume":"239","author":"M Navarro","year":"2023","unstructured":"Navarro M et al (2023) Indication for a pneumocystis prophylaxis therapy in patients with vascular anomalies treated with PIK3\/AKT\/mTOR pathway inhibitors: experts\u2019 opinion and systematic review from the literature. Dermatology 239(6):942\u2013951","journal-title":"Dermatology"},{"key":"5790_CR8","doi-asserted-by":"publisher","first-page":"106165","DOI":"10.1016\/j.ijsu.2021.106165","volume":"96","author":"G Mathew","year":"2021","unstructured":"Mathew G et al (2021) STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int J Surg 96:106165","journal-title":"Int J Surg"},{"issue":"6","key":"5790_CR9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/MOP.0000000000000812","volume":"31","author":"A Martinez-Lopez","year":"2019","unstructured":"Martinez-Lopez A et al (2019) Vascular malformations syndromes: an update. Curr Opin Pediatr 31(6):747\u2013753","journal-title":"Curr Opin Pediatr"},{"issue":"9","key":"5790_CR10","doi-asserted-by":"publisher","first-page":"e2124760","DOI":"10.1001\/jamanetworkopen.2021.24760","volume":"4","author":"J Lu","year":"2021","unstructured":"Lu J et al (2021) Characteristics and research waste among randomized clinical trials in gastric cancer. JAMA Netw Open 4(9):e2124760","journal-title":"JAMA Netw Open"},{"key":"5790_CR11","doi-asserted-by":"publisher","first-page":"c332","DOI":"10.1136\/bmj.c332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz KF et al (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 340:c332","journal-title":"BMJ"},{"issue":"4","key":"5790_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.7326\/0003-4819-148-4-200802190-00008","volume":"148","author":"I Boutron","year":"2008","unstructured":"Boutron I et al (2008) Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 148(4):295\u2013309","journal-title":"Ann Intern Med"},{"key":"5790_CR13","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP et al (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928","journal-title":"BMJ"},{"issue":"9","key":"5790_CR14","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/jama.2019.9892","volume":"322","author":"DA Zarin","year":"2019","unstructured":"Zarin DA, Goodman SN, Kimmelman J (2019) Harms from uninformative clinical trials. JAMA 322(9):813\u2013814","journal-title":"JAMA"},{"issue":"4","key":"5790_CR15","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1097\/PRS.0b013e3181d18070","volume":"125","author":"AS Liu","year":"2010","unstructured":"Liu AS et al (2010) Extracranial arteriovenous malformations: natural progression and recurrence after treatment. Plast Reconstr Surg 125(4):1185\u20131194","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"5790_CR16","doi-asserted-by":"publisher","first-page":"150969","DOI":"10.1016\/j.sempedsurg.2020.150969","volume":"29","author":"GM Olsen","year":"2020","unstructured":"Olsen GM, Nackers A, Drolet BA (2020) Infantile and congenital hemangiomas. Semin Pediatr Surg 29(5):150969","journal-title":"Semin Pediatr Surg"},{"issue":"6","key":"5790_CR17","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.ejvs.2020.01.023","volume":"59","author":"Y Sun","year":"2020","unstructured":"Sun Y et al (2020) Bleomycin Polidocanol Foam (BPF) Stability - in vitro evidence for the effectiveness of a novel sclerosant for venous malformations. Eur J Vasc Endovasc Surg 59(6):1011\u20131018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"5790_CR18","doi-asserted-by":"publisher","first-page":"106837","DOI":"10.1016\/j.ejps.2024.106837","volume":"200","author":"B Liu","year":"2024","unstructured":"Liu B et al (2024) Model-informed individualized dosage regimen of sirolimus in pediatric patients with intractable lymphatic malformations. Eur J Pharm Sci 200:106837","journal-title":"Eur J Pharm Sci"},{"key":"5790_CR19","doi-asserted-by":"publisher","first-page":"1221745","DOI":"10.3389\/fgene.2023.1221745","volume":"14","author":"Y Yoh","year":"2023","unstructured":"Yoh Y et al (2023) Case report: progressive pulmonary artery hypertension in a case of megalencephaly-capillary malformation syndrome. Front Genet 14:1221745","journal-title":"Front Genet"},{"issue":"7","key":"5790_CR20","doi-asserted-by":"publisher","first-page":"108437","DOI":"10.1016\/j.ejso.2024.108437","volume":"50","author":"L Lin","year":"2024","unstructured":"Lin L et al (2024) Research waste among randomized controlled trials in ovarian cancer: a cross-sectional study. Eur J Surg Oncol 50(7):108437","journal-title":"Eur J Surg Oncol"},{"issue":"9805","key":"5790_CR21","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/S0140-6736(11)61772-8","volume":"378","author":"A Liberati","year":"2011","unstructured":"Liberati A (2011) Need to realign patient-oriented and commercial and academic research. Lancet 378(9805):1777\u20131778","journal-title":"Lancet"},{"issue":"6","key":"5790_CR22","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/sj.bjc.6603662","volume":"96","author":"J Corner","year":"2007","unstructured":"Corner J et al (2007) The research priorities of patients attending UK cancer treatment centres: findings from a modified nominal group study. Br J Cancer 96(6):875\u2013881","journal-title":"Br J Cancer"},{"issue":"9912","key":"5790_CR23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0140-6736(13)62297-7","volume":"383","author":"R Al-Shahi Salman","year":"2014","unstructured":"Al-Shahi Salman R et al (2014) Increasing value and reducing waste in biomedical research regulation and management. Lancet 383(9912):176\u2013185","journal-title":"Lancet"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-024-05790-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-024-05790-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-024-05790-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T07:08:36Z","timestamp":1728889716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-024-05790-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,24]]},"references-count":23,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["5790"],"URL":"https:\/\/doi.org\/10.1007\/s00431-024-05790-2","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,24]]},"assertion":[{"value":"10 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. The Ethics Board of Shanghai Ninth Hospital, Shanghai Jiao Tong University School of Medicine concluded that this cross-sectional analysis, being a scrutiny of registered RCTs, did not necessitate ethical approval for research nor the need for informed consent from participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study does not involve participants; therefore, informed consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}